Furthermore, EGCG inhibits TGF-β-induced EMT in human cervical cancer (Hela and SiHa) and anaplastic thyroid carcinoma (8505C) cells via the ROS/Smad signaling [568–570]. Here, TGFB1 is linked to cervical carcinoma.